Global Colorectal Cancer Molecular Diagnostics Market Research Report - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2033)
Description
Definition and Scope:
Colorectal cancer molecular diagnostics refer to the use of advanced genetic testing techniques to analyze specific genes, proteins, or other molecules associated with colorectal cancer. These diagnostics help in identifying the presence of cancer, determining the prognosis, and guiding treatment decisions. By analyzing the genetic makeup of the tumor cells, healthcare providers can personalize treatment plans for patients, leading to more effective outcomes. Colorectal cancer molecular diagnostics play a crucial role in the early detection and management of this type of cancer, ultimately improving patient care and survival rates.
The market for colorectal cancer molecular diagnostics is experiencing significant growth due to several key market trends and drivers. One of the primary trends driving market growth is the increasing incidence of colorectal cancer globally. As the prevalence of this type of cancer rises, there is a growing need for accurate and efficient diagnostic tools to aid in its detection and treatment. Additionally, advancements in technology have led to the development of more sophisticated molecular diagnostic tests, which offer higher sensitivity and specificity in detecting colorectal cancer markers. This trend is further fueling the adoption of molecular diagnostics in colorectal cancer management.
Moreover, the shift towards personalized medicine in oncology is another major driver shaping the colorectal cancer molecular diagnostics market. Healthcare providers are increasingly recognizing the importance of tailoring treatment strategies based on the individual genetic profile of each patient. Molecular diagnostics play a crucial role in this personalized approach by providing insights into the specific molecular alterations driving colorectal cancer in each patient. As a result, there is a growing demand for molecular diagnostic tests that can accurately identify these genetic variations and help oncologists make informed decisions regarding targeted therapies. This trend is expected to continue driving the growth of the colorectal cancer molecular diagnostics market in the coming years.
This report offers a comprehensive analysis of the global Colorectal Cancer Molecular Diagnostics market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.
Report Framework and Key Highlights:
Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Colorectal Cancer Molecular Diagnostics market.
Global Colorectal Cancer Molecular Diagnostics Market: Segmentation Analysis and Strategic Insights
This section of the report provides an in-depth segmentation analysis of the global Colorectal Cancer Molecular Diagnostics market. The market is segmented based on region (country), manufacturer, product type, and application. Segmentation enables a more precise understanding of market dynamics and facilitates targeted strategies across product development, marketing, and sales.
By breaking the market into meaningful subsets, stakeholders can better tailor their offerings to the specific needs of each segment—enhancing competitiveness and improving return on investment.
Global Colorectal Cancer Molecular Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Market Segmentation by Type
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Market Segmentation by Application
Hospital
Third-Party Testing Agency
Others
Geographic Segmentation
North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA
Report Framework and Chapter Summary
Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Colorectal Cancer Molecular Diagnostics Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 4: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapters 5–10: Regional Market Analysis
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 11: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 12: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapter 13: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 14: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 15: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.
Colorectal cancer molecular diagnostics refer to the use of advanced genetic testing techniques to analyze specific genes, proteins, or other molecules associated with colorectal cancer. These diagnostics help in identifying the presence of cancer, determining the prognosis, and guiding treatment decisions. By analyzing the genetic makeup of the tumor cells, healthcare providers can personalize treatment plans for patients, leading to more effective outcomes. Colorectal cancer molecular diagnostics play a crucial role in the early detection and management of this type of cancer, ultimately improving patient care and survival rates.
The market for colorectal cancer molecular diagnostics is experiencing significant growth due to several key market trends and drivers. One of the primary trends driving market growth is the increasing incidence of colorectal cancer globally. As the prevalence of this type of cancer rises, there is a growing need for accurate and efficient diagnostic tools to aid in its detection and treatment. Additionally, advancements in technology have led to the development of more sophisticated molecular diagnostic tests, which offer higher sensitivity and specificity in detecting colorectal cancer markers. This trend is further fueling the adoption of molecular diagnostics in colorectal cancer management.
Moreover, the shift towards personalized medicine in oncology is another major driver shaping the colorectal cancer molecular diagnostics market. Healthcare providers are increasingly recognizing the importance of tailoring treatment strategies based on the individual genetic profile of each patient. Molecular diagnostics play a crucial role in this personalized approach by providing insights into the specific molecular alterations driving colorectal cancer in each patient. As a result, there is a growing demand for molecular diagnostic tests that can accurately identify these genetic variations and help oncologists make informed decisions regarding targeted therapies. This trend is expected to continue driving the growth of the colorectal cancer molecular diagnostics market in the coming years.
This report offers a comprehensive analysis of the global Colorectal Cancer Molecular Diagnostics market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.
Report Framework and Key Highlights:
Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Colorectal Cancer Molecular Diagnostics market.
Global Colorectal Cancer Molecular Diagnostics Market: Segmentation Analysis and Strategic Insights
This section of the report provides an in-depth segmentation analysis of the global Colorectal Cancer Molecular Diagnostics market. The market is segmented based on region (country), manufacturer, product type, and application. Segmentation enables a more precise understanding of market dynamics and facilitates targeted strategies across product development, marketing, and sales.
By breaking the market into meaningful subsets, stakeholders can better tailor their offerings to the specific needs of each segment—enhancing competitiveness and improving return on investment.
Global Colorectal Cancer Molecular Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Market Segmentation by Type
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Market Segmentation by Application
Hospital
Third-Party Testing Agency
Others
Geographic Segmentation
North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA
Report Framework and Chapter Summary
Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Colorectal Cancer Molecular Diagnostics Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 4: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapters 5–10: Regional Market Analysis
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 11: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 12: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapter 13: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 14: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 15: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.
Table of Contents
209 Pages
- 1 Introduction to Research & Analysis Reports
- 1.1 3'-Sialyllactose (3'-SL) Market Definition
- 1.2 3'-Sialyllactose (3'-SL) Market Segments
- 1.2.1 Segment by Type
- 1.2.2 Segment by Application
- 2 Executive Summary
- 2.1 Global 3'-Sialyllactose (3'-SL) Market Size
- 2.2 Market Segmentation – by Type
- 2.3 Market Segmentation – by Application
- 2.4 Market Segmentation – by Geography
- 3 Key Market Trends, Opportunity, Drivers and Restraints
- 3.1 Key Takeway
- 3.2 Market Opportunities & Trends
- 3.3 Market Drivers
- 3.4 Market Restraints
- 3.5 Market Major Factor Assessment
- 4 Global 3'-Sialyllactose (3'-SL) Market Competitive Landscape
- 4.1 Global 3'-Sialyllactose (3'-SL) Sales by Manufacturers (2020-2025)
- 4.2 Global 3'-Sialyllactose (3'-SL) Revenue Market Share by Manufacturers (2020-2025)
- 4.3 3'-Sialyllactose (3'-SL) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.4 New Entrant and Capacity Expansion Plans
- 4.5 Mergers & Acquisitions
- 5 Global 3'-Sialyllactose (3'-SL) Market by Region
- 5.1 Global 3'-Sialyllactose (3'-SL) Market Size by Region
- 5.1.1 Global 3'-Sialyllactose (3'-SL) Market Size by Region
- 5.1.2 Global 3'-Sialyllactose (3'-SL) Market Size Market Share by Region
- 5.2 Global 3'-Sialyllactose (3'-SL) Sales by Region
- 5.2.1 Global 3'-Sialyllactose (3'-SL) Sales by Region
- 5.2.2 Global 3'-Sialyllactose (3'-SL) Sales Market Share by Region
- 6 North America Market Overview
- 6.1 North America 3'-Sialyllactose (3'-SL) Market Size by Country
- 6.1.1 USA Market Overview
- 6.1.2 Canada Market Overview
- 6.1.3 Mexico Market Overview
- 6.2 North America 3'-Sialyllactose (3'-SL) Market Size by Type
- 6.3 North America 3'-Sialyllactose (3'-SL) Market Size by Application
- 6.4 Top Players in North America 3'-Sialyllactose (3'-SL) Market
- 7 Europe Market Overview
- 7.1 Europe 3'-Sialyllactose (3'-SL) Market Size by Country
- 7.1.1 Germany Market Overview
- 7.1.2 France Market Overview
- 7.1.3 U.K. Market Overview
- 7.1.4 Italy Market Overview
- 7.1.5 Spain Market Overview
- 7.1.6 Sweden Market Overview
- 7.1.7 Denmark Market Overview
- 7.1.8 Netherlands Market Overview
- 7.1.9 Switzerland Market Overview
- 7.1.10 Belgium Market Overview
- 7.1.11 Russia Market Overview
- 7.2 Europe 3'-Sialyllactose (3'-SL) Market Size by Type
- 7.3 Europe 3'-Sialyllactose (3'-SL) Market Size by Application
- 7.4 Top Players in Europe 3'-Sialyllactose (3'-SL) Market
- 8 Asia-Pacific Market Overview
- 8.1 Asia-Pacific 3'-Sialyllactose (3'-SL) Market Size by Country
- 8.1.1 China Market Overview
- 8.1.2 Japan Market Overview
- 8.1.3 South Korea Market Overview
- 8.1.4 India Market Overview
- 8.1.5 Australia Market Overview
- 8.1.6 Indonesia Market Overview
- 8.1.7 Malaysia Market Overview
- 8.1.8 Philippines Market Overview
- 8.1.9 Singapore Market Overview
- 8.1.10 Thailand Market Overview
- 8.1.11 Rest of APAC Market Overview
- 8.2 Asia-Pacific 3'-Sialyllactose (3'-SL) Market Size by Type
- 8.3 Asia-Pacific 3'-Sialyllactose (3'-SL) Market Size by Application
- 8.4 Top Players in Asia-Pacific 3'-Sialyllactose (3'-SL) Market
- 9 South America Market Overview
- 9.1 South America 3'-Sialyllactose (3'-SL) Market Size by Country
- 9.1.1 Brazil Market Overview
- 9.1.2 Argentina Market Overview
- 9.1.3 Columbia Market Overview
- 9.2 South America 3'-Sialyllactose (3'-SL) Market Size by Type
- 9.3 South America 3'-Sialyllactose (3'-SL) Market Size by Application
- 9.4 Top Players in South America 3'-Sialyllactose (3'-SL) Market
- 10 Middle East and Africa Market Overview
- 10.1 Middle East and Africa 3'-Sialyllactose (3'-SL) Market Size by Country
- 10.1.1 Saudi Arabia Market Overview
- 10.1.2 UAE Market Overview
- 10.1.3 Egypt Market Overview
- 10.1.4 Nigeria Market Overview
- 10.1.5 South Africa Market Overview
- 10.2 Middle East and Africa 3'-Sialyllactose (3'-SL) Market Size by Type
- 10.3 Middle East and Africa 3'-Sialyllactose (3'-SL) Market Size by Application
- 10.4 Top Players in Middle East and Africa 3'-Sialyllactose (3'-SL) Market
- 11 3'-Sialyllactose (3'-SL) Market Segmentation by Type
- 11.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 11.2 Global 3'-Sialyllactose (3'-SL) Sales Market Share by Type (2020-2033)
- 11.3 Global 3'-Sialyllactose (3'-SL) Market Size Market Share by Type (2020-2033)
- 11.4 Global 3'-Sialyllactose (3'-SL) Price by Type (2020-2033)
- 12 3'-Sialyllactose (3'-SL) Market Segmentation by Application
- 12.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 12.2 Global 3'-Sialyllactose (3'-SL) Market Sales by Application (2020-2033)
- 12.3 Global 3'-Sialyllactose (3'-SL) Market Size (M USD) by Application (2020-2033)
- 12.4 Global 3'-Sialyllactose (3'-SL) Sales Growth Rate by Application (2020-2033)
- 13 Company Profiles
- 13.1 Chr. Hansen (Jennewein Biotechnologie GmgH)
- 13.1.1 Chr. Hansen (Jennewein Biotechnologie GmgH) Company Overview
- 13.1.2 Chr. Hansen (Jennewein Biotechnologie GmgH) Business Overview
- 13.1.3 Chr. Hansen (Jennewein Biotechnologie GmgH) 3'-Sialyllactose (3'-SL) Major Product Offerings
- 13.1.4 Chr. Hansen (Jennewein Biotechnologie GmgH) 3'-Sialyllactose (3'-SL) Sales and Revenue from3'-Sialyllactose (3'-SL) (2020-2025)
- 13.1.5 Key News
- 13.2 DSM (Glycom A/S)
- 13.2.1 DSM (Glycom A/S) Company Overview
- 13.2.2 DSM (Glycom A/S) Business Overview
- 13.2.3 DSM (Glycom A/S) 3'-Sialyllactose (3'-SL) Major Product Offerings
- 13.2.4 DSM (Glycom A/S) 3'-Sialyllactose (3'-SL) Sales and Revenue from3'-Sialyllactose (3'-SL) (2020-2025)
- 13.2.5 Key News
- 13.3 Inbiose
- 13.3.1 Inbiose Company Overview
- 13.3.2 Inbiose Business Overview
- 13.3.3 Inbiose 3'-Sialyllactose (3'-SL) Major Product Offerings
- 13.3.4 Inbiose 3'-Sialyllactose (3'-SL) Sales and Revenue from3'-Sialyllactose (3'-SL) (2020-2025)
- 13.3.5 Key News
- 13.4 Kyowa Hakko Bio
- 13.4.1 Kyowa Hakko Bio Company Overview
- 13.4.2 Kyowa Hakko Bio Business Overview
- 13.4.3 Kyowa Hakko Bio 3'-Sialyllactose (3'-SL) Major Product Offerings
- 13.4.4 Kyowa Hakko Bio 3'-Sialyllactose (3'-SL) Sales and Revenue from3'-Sialyllactose (3'-SL) (2020-2025)
- 13.4.5 Key News
- 13.5 GeneChem Inc.
- 13.5.1 GeneChem Inc. Company Overview
- 13.5.2 GeneChem Inc. Business Overview
- 13.5.3 GeneChem Inc. 3'-Sialyllactose (3'-SL) Major Product Offerings
- 13.5.4 GeneChem Inc. 3'-Sialyllactose (3'-SL) Sales and Revenue from3'-Sialyllactose (3'-SL) (2020-2025)
- 13.5.5 Key News
- 13.6 FrieslandCampina Ingredients
- 13.6.1 FrieslandCampina Ingredients Company Overview
- 13.6.2 FrieslandCampina Ingredients Business Overview
- 13.6.3 FrieslandCampina Ingredients 3'-Sialyllactose (3'-SL) Major Product Offerings
- 13.6.4 FrieslandCampina Ingredients 3'-Sialyllactose (3'-SL) Sales and Revenue from3'-Sialyllactose (3'-SL) (2020-2025)
- 13.6.5 Key News
- 14 Key Market Trends, Opportunity, Drivers and Restraints
- 14.1 Key Takeway
- 14.2 Market Opportunities & Trends
- 14.3 Market Drivers
- 14.4 Market Restraints
- 14.5 Market Major Factor Assessment
- 14.6 Porter's Five Forces Analysis of 3'-Sialyllactose (3'-SL) Market
- 14.7 PEST Analysis of 3'-Sialyllactose (3'-SL) Market
- 15 Analysis of the 3'-Sialyllactose (3'-SL) Industry Chain
- 15.1 Overview of the Industry Chain
- 15.2 Upstream Segment Analysis
- 15.3 Midstream Segment Analysis
- 15.3.1 Manufacturing, Processing or Conversion Process Analysis
- 15.3.2 Key Technology Analysis
- 15.4 Downstream Segment Analysis
- 15.4.1 Downstream Customer List and Contact Details
- 15.4.2 Customer Concerns or Preference Analysis
- 16 Conclusion
- 17 Appendix
- 17.1 Methodology
- 17.2 Research Process and Data Source
- 17.3 Disclaimer
- 17.4 Note
- 17.5 Examples of Clients
- 17.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
